Lionshead Wealth Management, LLC

Position in JNJ — Johnson & Johnson

CIK 2056752 New York, NY

Position in JNJ

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$246,350

+$16,577 QoQ

Shares Held

970

+3.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#4,352

of 4,664 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Lionshead Wealth Management, LLC holds $4,038,187 across 5 Drug Manufacturers - General names. JNJ ranks #5 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	4,720	$1,187,740
2	LLY	ELI LILLY & Co	969	$1,162,247
3	MRK	Merck & Co., Inc.	5,754	$739,389
4	PFE	Pfizer Inc	29,172	$702,461
5	JNJ	Johnson & Johnson This page	970	$246,350

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$246,350	970	+3.2%	Shares	Sole	2026-07-28
2026-03-31	$229,773	940	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.